Company Performance: Financial health (revenue, profit), operational efficiency, and strategic decisions significantly impact investor confidence and stock price.

Industry Trends: The overall performance and growth prospects of the healthcare sector, including pharmaceuticals and biotechnology, influence stock valuation.

Economic Conditions: Macroeconomic factors like inflation, interest rates, and economic growth affect investor sentiment and investment decisions.

Regulatory Changes: Government regulations, drug approvals, and healthcare policies can drastically alter the company's prospects and stock price.

Market Sentiment: General investor mood, risk appetite, and market volatility can lead to fluctuations in stock prices, regardless of company fundamentals.

Competition: The competitive landscape, including the presence of rivals and the introduction of new products, affects market share and profitability.